While AI adoption in GMP settings is still evolving, regulatory agencies emphasize explainability and validation of AI models.
process validation, part and device traceability, along with the applicable quality management systems. Imricor is executing ...
The new entry to FDA’s database of Recognized Consensus Standards is AAMI TIR106:2024: Microbiological methods—Understanding and use of product bioburden data. Three of AAMI’s most notable ...